ABC transporters in Leishmania and their role in drug resistance

Drug Resistance Updates

Volumn 1, Issue 1, 1998, Pages 43-48

  Ouellette, Marc ^a   Légaré, Danielle ^a   Haimeur, Anass ^a   Grondin, Katherine ^a   Roy, Gaétan ^a   Brochu, Christian ^a   Papadopoulou, Barbara ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0002328486     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-7646(98)80213-6     Document Type: Review

References (71)

1. Ashford R.W., Desjeux P., and deRaadt P. Estimation of population at risk of infection and number of cases of leishmaniasis. Parasitol Today 8 (1992) 104-105
2. Alvar J., Canavate C., Gutierrez-Solar B., et al. Leishmania and human immunodeficiency virus co-infection: the first 10 years. Clin Microb Rev 10 (1997) 298-319
3. Olliaro P.L., and Bryceson A. Practical progress and new drugs for changing patterns of leishmaniasis. Parasitol Today 9 (1993) 323-328
4. Berman J.D., and Grogl M. Leishmania mexicana: chemistry and biochemistry of sodium stibogluconate (Pentostam). Exp Parasitol 67 (1988) 96-103
5. Borst P., and Ouellette M. New mechanisms of drug resistance in parasitic protozoa. Annu Rev Microbiol 49 (1995) 427-460
6. Jackson J.E., Tally J.D., Ellis W.Y., et al. Quantitative in vitro drug potency and drug susceptibility evaluation of Leishmania spp. from patients unresponsive to pentavalent antimony therapy. Am J Trop Med Hyg 43 (1990) 464-480
7. Grogl M., Thomason T.N., and Franke E.D. Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease. Am J Trop Med Hyg 47 (1992) 117-126
8. Faraut-Gambarelli F., Piarroux R., Deniau M., et al. In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis. Antimicrob Agents Chemother 41 (1997) 827-830
9. Ouellette M., Fase-Fowler F., and Borst P. The amplified H circle of methotrexate-resistant Leishmania tarentolae contains a novel P-glycoprotein gene. EMBO J 9 (1990) 1027-1033
10. Higgins C.F. ABC Transporters from microorganisms to man. Annu Rev Cell Biol 8 (1992) 67-113
11. Doige C.A., and Ames G.-L. ATP-dependent transport systems in bacteria and humans: relevance to cystic fibrosis and multidrug resistance. Annu Rev Microbiol 47 (1993) 291-319
12. Blattner F.R., Plunkett III G., Bloch C.A., et al. The complete genome sequence of Escherichia coli K-12. Science 277 (1997) 1453-1462
13. Gottesman M.M., and Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62 (1993) 385-427
14. Cole S.P.C., Bhardwaj G., Gerlach J.H., et al. Overexpression of a transporter gene in a multidrug-resistant human cancer cell line. Science 258 (1992) 1650-1654
15. Loe D.W., Deeley R.G., and Cole S.P.C. Biology of the multidrug resistance-associated protein MRP. Eur J Cancer 32A (1996) 945-957
16. Zaman G.J.R., and Borst P. MRP, mode of action and role in MDR. In: Gupta S., and Tsuoro T. (Eds). Multidrug Resistance in Cancer Cells (1996), John Wiley and Sons, New York 95-107
17. Ishikawa T., Li Z.S., Lu Y.P., and Rea P.A. The GS-X pump in plant, yeast, and animal cells: structure, function, and gene expression. Biosci Rep 17 (1997) 189-207
18. Keppler D., Leir I., and Jedlitschtey G. Transport of glutathione conjugates and glucoronides by the multidrug resistance proteins MRP1 and MRP2. Biol Chem 278 (1997) 787-791
19. Ouellette M., Légaré D., and Papadopoulou B. Microbial ABC transporters. Trends Microbiol 2 (1994) 407-411
20. Foote S.J., Thompson J.K., Cowman A.F., and Kemp D.J. Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of Plasmodium falciparum. Cell 57 (1989) 921-930
21. Wilson C.W., Serrano A.E., Wasley A., Bogenschutz M.P., Shankar A.H., and Wirth D.F. Amplification of a gene related to mammalian mdr genes in drug resistant Plasmodium falciparum. Science 244 (1989) 1184-1186
22. Ullman B. Multidrug resistance and P-glycoproteins in parasitic protozoa. J Bioenerg Biomembr 27 (1995) 77-84
23. Beverley S.M. Gene amplification in Leishmania. Annu Rev Microbiol 45 (1991) 417-444
24. Stuart K.D. Circular and linear multicopy DNAs in Leishmania. Parasitol Today 7 (1991) 158-159
25. Segovia M. Leishmania gene amplification: a mechanism of drug resistance. Ann Trop Med Parasitol 88 (1994) 123-130
26. Ouellette M., and Papadopoulou B. Mechanisms of drug resistance in Leishmania. Parasitol Today 9 (1993) 150-153
27. Ouellette M., and Borst P. Drug resistance and P-glycoprotein gene amplification in the protozoan parasite Leishmania. Res Microbiol 142 (1991) 737-746
28. Detke S., Katakura K., and Chang K.-P. DNA amplification in arseniteresistant Leishmania. Exp Cell Res 180 (1989) 161-170
29. Ouellette M., Hettema E., Wüst D., Fase-Fowler F., and Borst P. Direct and inverted DNA repeats associated with P-glycoprotein gene amplification in drug-resistant Leishmania. EMBO J 10 (1991) 1009-11016
30. Grondin K., Papadopoulou B., and Ouellette M. Homologous recombination between direct repeat sequences yields P-glycoprotein containing circular amplicons in arsenite resistant Leishmania. Nucleic Acids Res 21 (1993) 1895-1901
31. Singh A.K., Liu H.Y., and Lee S.T. Atomic absorption spectrophotometric measurement of intracellular arsenite in arsenite-resistant Leishmania. Mol Biochem Parasitol 66 (1994) 161-164
32. Légaré D., Papadopoulou B., Roy G., et al. Efflux systems and increased trypanothione levels in arsenite resistant Leishmania species. Exp Parasitol 87 (1997) 275-282
33. Callahan H.L., and Beverley S.M. Heavy metal resistance: a new role for P-glycoproteins in Leishmania. J Biol Chem 266 (1991) 18427-18430
34. Papadopoulou B., Roy G., Dey S., Rosen B.P., and Ouellette M. Contribution of the Leishmania P-glycoprotein related gene ItpgpA to oxyanion resistance. J Biol Chem 269 (1994) 11980-11986
35. Mukhopadhyay R., Dey S., Xu N., et al. Trypanothione overproduction and resistance to antimonials and arsenicals in Leishmania tarentolae. Proc Natl Acad Sci USA 93 (1996) 10383-10387
36. Fairlamb A.H., and Cerami A. Metabolism and functions of trypanothione in the Kinetoplastida. Annu Rev Microbiol 46 (1992) 695-729
37. Grondin K., Haimeur A., Mukhopadhyay R., Rosen B.P., and Ouellette M. Co-amplification of the γ-glutamylcysteine synthetase gene gshI and of the ABC transporter gene pgpA in arsenite-resistant Leishmania tarentolae. EMBO J 16 (1997) 3057-3065
38. Ishikawa T. The ATP-dependent glutathione S-conjugate export pump. Trends Biochem Sci 17 (1992) 463-468
39. Delnomdedieu M., Basti M.M., Otvos J.O., and Thomas D.J. Reduction of arsenate and dimethlyarsinate by glutathione: a magnetic resonance study. Chem Biol Interact 90 (1994) 139-155
40. Wang H.-F., and Lee T.-C. Glutathione S-transferase π facilitates the excretion of arsenic from arsenic-resistant chinese hamster ovary cells. Biochem Biophys Res Commun 192 (1993) 1093-1099
41. Callahan H.L., Roberts W.L., Rainey P.M., and Beverley S.M. The pgpA gene of Leishmania major mediates antimony (SbIII) resistance by decreasing influx and not by increasing efflux. Mol Biochem Parasitol 68 (1994) 145-150
42. Dey S., Papadopoulou B., Roy G., et al. High level arsenite resistance in Leishmania tarentolae is mediated by an active extrusion system. Mol Biochem Parasitol 67 (1994) 49-57
43. Dey S., Ouellette M., Lightbody J., Papadopoulou B., and Rosen B.P. A novel ATP-dependent As(+ 3)-glutathione transport system in plasma membrane vesicles of Leishmania tarentolae. Proc Natl Acad Sci USA 93 (1996) 2192-2197
44. Papadopoulou B., Roy G., Dey S., Rosen B.P., Olivier M., and Ouellette M. Gene disruption of the P-glycoprotein related gene pgpA of Leishmania tarentolae. Biochem Biophys Res Commun 224 (1996) 772-778
45. Li Z.-H., Szczypka M., Lu Y.-P., Thiele D.J., and Rea P.A. The yeast cadmium factor protein (YCFI) is a vacuolar glutathione S-conjugate pump. J Biol Chem 271 (1996) 6509-6517
46. Tommasini R., Evers R., Vogt E., et al. The human multidrug resistance-associated protein functionally complements the yeast cadmium resistance factor I. Proc Natl Acad Sci USA 93 (1996) 6743-6748
47. Ishikawa T., Wright C.D., and Ishizuka H. GS-X pump is functionally overexpressed in cis-diamminedichloroplatinum (II)-resistant human leukemia HL-60 cells and down-regulated by cell differentiation. J Biol Chem 269 (1994) 29085-29093
48. Ferreira-Pinto K.C., Miranda-Vilela A.L., Anacleto C., et al. Leishmania (V.) guyanensis: isolation and characterization of glucantime-resistant cell lines. Can J Microbiol 42 (1996) 944-949
49. Roberts W.L., Berman J.D., and Rainey P.M. In vitro antileishmanial properties of tri- and pentavalent antimonial preparations. Antimicrob Agents Chemother 39 (1995) 1234-1239
50. Callahan H.L., Portal A.C., Devereaux R., and Grogl M. An axenic amastigote system for drug screening. Antimicrob Agents Chemother 41 (1997) 818-822
51. Ephros M., Waldman E., and Zilberstein D. Pentostam induces resistance to antimony and the preservative chlorocresol in Leishmania donovani promastigotes and axenically grown amastigotes. Antimicrob Agents Chemother 41 (1997) 1064-1068
52. Zaman G.J.R., Lankelma J., van Tellingen O., et al. Role of glutathione in the export of compounds from cells by the multidrug resistance-associated protein. Proc Natl Acad Sci USA 92 (1995) 7690-7694
53. Chen Z.-S., Mutoh M., Sumizawa T., et al. Reversal of heavy metal resistance in multidrug-resistant human KB carcinoma cells. Biochem Biophys Res Com 236 (1997) 586-590
54. Rosen B.P. Resistance mechanisms to arsenicals and antimonials. J Basic Clin Physiol Pharmacol 6 (1995) 251-263
55. Cole S.P.C., Sparks K.E., Fraser K., et al. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res 54 (1994) 5902-5910
56. Lorico A., Rappa G., Flavell R.A., and Sartorelli A.C. Double knockout of the MRP gene leads to increased drug sensitivity in vitro. Cancer Res 56 (1996) 5351-5355
57. Broeks A., Gerrard B., Allikmets R., Dean M., and Plasterk R. Homologues of the human multidrug resistance genes MRP and MDR contribute to heavy metal resistance in the soil nematode Caenorhabditis elegans. EMBO J 15 (1996) 6132-6143
58. Ortiz D.F., Ruscitti T., McCue K.F., and Ow D.W. Transport of metal-binding peptides by HMTI, a fission yeast ABC-type vacuolar membrane protein. J Biol Chem 270 (1995) 4721-4728
59. Huang R.N., and Lee T.C. Arsenite efflux is inhibited by verapamil, cyclosporin A, and GSH-depleting agents in arsenite-resistant Chinese hamster ovary cells. Toxicol Appl Pharmacol 141 (1996) 17-22
60. Henderson D.M., Sifri C.D., Rodgers M., Wirth D.F., Hendrickson N., and Ullman B. Multidrug resistance in Leishmania donovani is conferred by amplification of a gene homologous to the mammalian mdrI gene. Mol Cell Biol 12 (1992) 2855-2865
61. Hendrickson N., Sifri C.D., Henderson D.M., Allen T., Wirth D.F., and Ullman B. Molecular characterization of the ldmdrI multidrug resistance gene from Leishmania donovani. Mol Biochem Parasitol 60 (1993) 53-64
62. Chow L.M.C., Wong A., Ullman B., and Wirth D.F. Cloning and functional analysis of an extrachromosomally amplified multidrug resistance-like gene in Leishmania enriettii. Mol Biochem Parasitol 60 (1993) 195-208
63. Wong A., Chow L.M.C., and Wirth D.F. A homologous recombination strategy to analyse the vinblastine resistance property of the V-circle in Leishmania. Mol Biochem Parasitol 64 (1994) 75-86
64. Gueiros-Filho F.J., Viola J.P.B., Gomez F., et al. Leishmania amazonensis: multidrug resistance in vinblastine-resistant promastigotes is associated with rhodamine 123 efflux, DNA amplification, and RNA overexpression of a Leishmania mdrI gene. Exp Parasitol 81 (1995) 480-490
65. Neyfakh A.A. Use of fluorescent dyes as molecular probes for study of multidrug resistance. Exp Cell Res 174 (1988) 168-176
66. Chow LM, Srivastava IK, Vaidya A, Wirth DF. The role of leMDRI in the accumulation of and resistance to mitochondrial drugs in Leishmania enriettii. Woods Hole Molecular Parasitology meeting, abstract 78.
67. Légaré D., Hettema E., and Ouellette M. The P-glycoprotein related gene family in Leishmania. Mol Biochem Parasitol 68 (1994) 81-91
68. Gamarro F., Amador M.V., Chiquero M.J., Légaré D., Ouellette M., and Castanys S. Multidrug resistance phenotype and P-glycoprotein overexpression in a methotrexate-resistant Leishmania infantum. Biochem Pharmacol 47 (1994) 1939-1947
69. Georges E., Bradley G., Gariepy J., and Ling V. Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies. Proc Natl Acad Sci USA 87 (1990) 152-156
70. Grogl M., Martin R.K., Odula A., Milhous W.K., and Kyle D.E. Characteristics of multidrug resistance in Plasmodium and Leishmania: detection of P-glycoprotein-like components. Am J Trop Med Hyg 45 (1991) 98-111
71. Decottignies A., and Goffeau A. Complete inventory of the yeast ABC proteins. Nature Genet 15 (1997) 137-145